SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-043045
Filing Date
2023-11-29
Accepted
2023-11-29 16:01:18
Documents
14
Period of Report
2023-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41102
2 ex10-1.htm EX-10.1 341262
3 ex10-2.htm EX-10.2 18794
  Complete submission text file 0001493152-23-043045.txt   621044

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atrx-20231122.xsd EX-101.SCH 3030
5 XBRL LABEL FILE atrx-20231122_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE atrx-20231122_pre.xml EX-101.PRE 22369
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 2944
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 231452103
SIC: 2834 Pharmaceutical Preparations